A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study
โ Scribed by Bill L. Tranum; Arthur Haut; Saul Rivkin; Edward Weber; Joseph M. Quagliana; Michael Shaw; William G. Tucker; Frank E. Smith; Michael Samson; Jeffrey Gottlieb
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 450 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Bleomycin given intravenously (i.v.) or intramuscularly (i.m.) in twice-weekly doses of 10 mg/mz was evaluated for efficacy and toxicity in 382 patients. Responses were observed in 11/27 Hodgkin's diseases, 10/30 lymphomas, 9/22 squamous cell cancers of ectodermal origin, 12/26 germinal cancers, and
Thirty-two patients with advanced, inoperable nonhematologic soft-tissue and osseous sarcomas were treated with Methyl CCNU administered via controlled intravenous infusion in doses of 130-170 mg/m2 every 6 weeks in a Phase I1 trial. All 28 evaluable patients were no longer responsive to adriamycin.
n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our